Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 43, Issue 10 In this issue Research Highlight Perspective Article In Memoriam Also new AOP   Research Highlight Sound of silent synapses from the addicted hippocampus Eisuke Koya & Yan Dong Neuropsychopharmacology 2018 43 :1981 - 1982; July 20, 2018; 10.1038/s41386-018-0142-5   Abstract | Full Text Can anti-obesity drugs be repurposed to treat cocaine addiction? David J. Reiner & Jennifer M. Bossert Neuropsychopharmacology 2018 43 :1983 - 1984; April 17, 2018; 10.1038/s41386-018-0035-7   Abstract | Full Text Perspective Does human language limit translatability of clinical and preclinical addiction research? Harriet de Wit, David H. Epstein & Kenzie L. Preston Neuropsychopharmacology 2018 43 :1985 - 1988; May 17, 2018; 10.1038/s41386-018-0095-8   Abstract | Full Text Article Generation of silent synapses in dentate gyrus correlates with development of alcohol addiction Anna Beroun, Maria Nalberczak-Skóra, Zofia Harda, Malgorzata Piechota, Magdalena Ziólkowska et al. Neuropsychopharmacology 2018 43 :1989 - 1999; June 15, 2018; 10.1038/s41386-018-0119-4   Abstract | Full Text Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats Nicole S. Hernandez, Kelsey Y. Ige, Elizabeth G. Mietlicki-Baase, Gian Carlo Molina-Castro, Christopher A. Turner et al. Neuropsychopharmacology 2018 43 :2000 - 2008; February 14, 2018; 10.1038/s41386-018-0010-3   Abstract | Full Text Neurocognitive effects of umami: association with eating behavior and food choice Greta Magerowski, Gabrielle Giacona, Laura Patriarca, Konstantinos Papadopoulos, Paola Garza-Naveda et al. Neuropsychopharmacology 2018 43 :2009 - 2016; March 30, 2018; 10.1038/s41386-018-0044-6   Abstract | Full Text Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity Amir Segev, Nachshon Korem, Tomer Mizrachi Zer-Aviv, Hila Abush, Rachel Lange et al. Neuropsychopharmacology 2018 43 :2017 - 2027; June 27, 2018; 10.1038/s41386-018-0135-4   Abstract | Full Text Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway Inés Ibarra-Lecue, Irene Mollinedo-Gajate, J Javier Meana, Luis F Callado, Rebeca Diez-Alarcia et al. Neuropsychopharmacology 2018 43 :2028 - 2035; April 27, 2018; 10.1038/s41386-018-0076-y   Abstract | Full Text Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle Gustavo Gonzalez-Cuevas, Remi Martin-Fardon, Tony M. Kerr, David G. Stouffer, Loren H. Parsons et al. Neuropsychopharmacology 2018 43 :2036 - 2045; March 22, 2018; 10.1038/s41386-018-0050-8   Abstract | Full Text Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability Ziva D. Cooper, Gillinder Bedi, Divya Ramesh, Rebecca Balter, Sandra D. Comer et al. Neuropsychopharmacology 2018 43 :2046 - 2055; February 05, 2018; 10.1038/s41386-018-0011-2   Abstract | Full Text Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease Dan P. Covey, Hannah M. Dantrassy, Samantha E. Yohn, Alberto Castro, P. Jeffrey Conn et al. Neuropsychopharmacology 2018 43 :2056 - 2063; June 01, 2018; 10.1038/s41386-018-0107-8   Abstract | Full Text Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol Benjamin A. Harlan, Howard C. Becker, John J. Woodward & Arthur C. Riegel Neuropsychopharmacology 2018 43 :2064 - 2074; June 09, 2018; 10.1038/s41386-018-0106-9   Abstract | Full Text mGlu1 and mGlu5 modulate distinct excitatory inputs to the nucleus accumbens shell Brandon D. Turner, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn & Brad A. Grueter Neuropsychopharmacology 2018 43 :2075 - 2082; March 27, 2018; 10.1038/s41386-018-0049-1   Abstract | Full Text Burst activation of dopamine neurons produces prolonged post-burst availability of actively released dopamine Sweyta Lohani, Adria K. Martig, Suzanne M. Underhill, Alicia DeFrancesco, Melanie J. Roberts et al. Neuropsychopharmacology 2018 43 :2083 - 2092; May 07, 2018; 10.1038/s41386-018-0088-7   Abstract | Full Text Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways David M. Bortz & Anthony A. Grace Neuropsychopharmacology 2018 43 :2093 - 2100; March 27, 2018; 10.1038/s41386-018-0048-2   Abstract | Full Text Multiple long-range inputs evoke NMDA currents in prefrontal cortex fast-spiking interneurons Luke Joseph Bogart & Patricio O'Donnell Neuropsychopharmacology 2018 43 :2101 - 2108; February 26, 2018; 10.1038/s41386-018-0029-5   Abstract | Full Text Involvement of dopamine, but not norepinephrine, in the sex-specific regulation of juvenile socially rewarding behavior by vasopressin Remco Bredewold, Nara F. Nascimento, Grace S. Ro, Shannon E. Cieslewski, Christina J. Reppucci et al. Neuropsychopharmacology 2018 43 :2109 - 2117; May 22, 2018; 10.1038/s41386-018-0100-2   Abstract | Full Text Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice Yann S. Mineur, Emma L. Cahuzac, Tenna N. Mose, Matthew P. Bentham, Margreet E. Plantenga et al. Neuropsychopharmacology 2018 43 :2118 - 2125; February 22, 2018; 10.1038/s41386-018-0024-x   Abstract | Full Text Glutamatergic and gabaergic ventral BNST neurons differ in their physiological properties and responsiveness to noradrenaline Nur Zeynep Gungor, Ryo Yamamoto & Denis Pare Neuropsychopharmacology 2018 43 :2126 - 2133; April 20, 2018; 10.1038/s41386-018-0070-4   Abstract | Full Text Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression Lucia Carboni, Luca Marchetti, Mario Lauria, Peter Gass, Barbara Vollmayr et al. Neuropsychopharmacology 2018 43 :2134 - 2145; June 12, 2018; 10.1038/s41386-018-0117-6   Abstract | Full Text Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder Xiaoyan Li, Zhenwu Luo, Chunjie Gu, Lynsey S. Hall, Andrew M. McIntosh et al. Neuropsychopharmacology 2018 43 :2146 - 2153; April 27, 2018; 10.1038/s41386-018-0078-9   Abstract | Full Text The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects Chadi G. Abdallah, Henk M. De Feyter, Lynnette A. Averill, Lihong Jiang, Christopher L. Averill et al. Neuropsychopharmacology 2018 43 :2154 - 2160; June 28, 2018; 10.1038/s41386-018-0136-3   Abstract | Full Text In Memoriam Ronald R Fieve David L Dunner Neuropsychopharmacology 2018 43 :2161 - 2161; June 26, 2018; 10.1038/s41386-018-0045-5   Abstract | Full Text Ernest P. Noble Lewis R. Baxter Neuropsychopharmacology 2018 43 :2162 - 2162; June 11, 2018; 10.1038/s41386-018-0114-9   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.